Sep 09, 2021 / 12:40PM GMT
Operator
Welcome to the Wells Fargo Bank and Tech Pop-up Virtual Conference. Before we get started, if you are a member of the press or media, please disconnect at this time. This is a restricted line. Any unauthorized party in this meeting or any unauthorized use of the information communicated in this meeting is subject to prosecution to the fullest extent of the law. Any unauthorized person, including the media that is on the line at this time, please disconnect.
Nicholas M. Abbott - Wells Fargo Securities, LLC, Research Division - Director & Associate Analyst
Hello. My name is Nick Abbott, I'm one of the senior biotech analysts here at Wells. It's my pleasure to introduce Precigen and the company's CEO, Helen Sabzevari. I can say to Precigen, a platform company with a novel point of care, autologous CAR-T, a novel gorilla adenoviral vaccine platform and a novel engineered oral bacterial platform, and all of which are in the clinic. So with that, over to you, Helen, for a short introduction. Then we'll go to Q&A.
Helen Sabzevari -
Precigen Inc at Wells Fargo Virtual Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
